P057 Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness studies

Autor: L Schnitzler
Rok vydání: 2021
Předmět:
Zdroj: Poster presentations.
DOI: 10.1136/sextrans-2021-sti.199
Popis: Background This review aims to explore the intersectoral costs (costs spilling over to other non-health sectors) associated with sexually transmitted infections (STIs) and HIV are considered in cost-of-illness (COI) studies, and to categorise and analyse these costs according to sector. Methods Medline (PubMed), EMBASE (Ovid), Web of Science, CINAHL, PsycINFO, EconLit and NHS EED were searched. Key search terms included terms for cost-of-illness, cost analysis and all terms for HIV/STIs including specific infections. Studies were included that assessed costs beyond healthcare costs. A standardised data extraction form was adopted. A disease-specific cost component table was established based on pre-defined sector-specific classification schemes. Cost results for intersectoral costs were recorded. The quality of studies was assessed using a modified version of the CHEC-list. Results 75 COI studies were considered for title/abstract screening. Only six studies were available in full-text, and eligible for data extraction and narrative synthesis, having considered intersectoral costs in their analyses. Intersectoral costs were captured in the following sectors: Patient & family, Informal care, Leisure & domestic work, and Paid Labour. Patient & family costs were addressed in four studies, including patient out-of-pocket payments/co-payments and travel costs. Two studies considered household cost in terms of care provided by family/friends. All six studies estimated productivity costs for paid labour, including costs in terms of absenteeism, short-term/partial/long-term disability, cease-to-work, presenteeism, and premature death. Conclusion The importance of intersectoral costs has not been sufficiently highlighted in COI studies in this area. There is a lack of exploration of the wider costs associated with STIs and HIV that needs to be addressed in order to ensure the true economic burden of STIs/HIV on society is assessed and communicated to policy/decision-makers.
Databáze: OpenAIRE